Diagnosis and differential diagnosis of multiple sclerosis

CONTINUUM Lifelong Learning in Neurology

Volumn 19, Issue 4, 2013, Pages 922-943

  Sand, Ilana B Katz ^a   Lublin, Fred D ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

BRAIN STEM; BRAINSTEM SYNDROME; CEREBELLUM APLASIA; CEREBROSPINAL FLUID EXAMINATION; CLINICAL FEATURE; DEMYELINATING DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; HUMAN; MCDONALD 2010 CRITERIA; MULTIPLE SCLEROSIS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; OPTIC NEURITIS; PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS; PROGRESSIVE RELAPSING MULTIPLE SCLEROSIS; REVIEW; SPINAL CORD; SPINAL CORD SYNDROME; SYMPTOM;

ADULT; BRAIN DISEASES; DIABETES INSIPIDUS; DIAGNOSIS, DIFFERENTIAL; HUMANS; INCIDENTAL FINDINGS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; OPTIC NEURITIS; POSITRON-EMISSION TOMOGRAPHY; SPINAL CORD DISEASES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84881644039     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/01.CON.0000433290.15468.21     Document Type: Review

References (35)

1. Gafson A, Giovannoni G, Hawkes CH. The diagnostic criteria for multiple sclerosis: from Charcot to McDonald. Mult Scler Rel Disord 2012;1(1):9-14.
2. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50(1):121-127.
3. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005;58(6):840-846.
4. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69(2):292-302.
5. Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997;120(pt 11):2059-2069.
6. Tintoré M, Rovira A, Martinez MJ, et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol 2000;21(4):702-706.
7. McHugh JC, Galvin PL, Murphy RP. Retrospective comparison of the original and revised McDonald criteria in a general neurology practice in ireland. Mult Scler 2008;14(1):81-85.
8. Montalban X, Tintoré M, Swanton J, et al. MRI criteria for MS in patients with clinically isolated syndromes. Neurology 2010;74(5): 427-434.
9. Tur C, Tintoré M, Rovira A, et al. Very early scans for demonstrating dissemination in time in multiple sclerosis. Mult Scler 2008; 14(5):631-635.
10. Rovira A, Swanton J, Tintoré M, et al. A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis. Arch Neurol 2009;66(5):587-592.
11. Miller DH, Leary SM. Primary-progressive multiple sclerosis. Lancet Neurol 2007;6(10): 903-912.
12. Koch M, Kingwell E, Rieckmann P, Tremlett H. The natural history of primary progressive multiple sclerosis. Neurology 2009;73(23):1996-2002.
13. Montalban X, Sastre-Garriga J, Filippi M, et al. Primary progressive multiple sclerosis diagnostic criteria: a reappraisal. Mult Scler (2009);15(12):1459-1465.
14. Rovaris M, Confavreux C, Furlan R, et al. Secondary progressive multiple sclerosis: current knowledge and future challenges. Lancet Neurol 2006;5(4):343-354.
15. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. national multiple sclerosis society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46(4):907-911.
16. Tullman MJ, Oshinsky RJ, Lublin FD, et al. Clinical characteristics of progressive relapsing multiple sclerosis. Mult Scler 2004;10(4):451-454.
17. Tintoré M, Rovira A, Rio J, et al. Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology 2006;67(6):968-972.
18. Okuda DT, Mowry EM, Beheshtian A, et al. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology 2009;72(9):800-805.
19. Okuda DT, Mowry EM, Cree BA, et al. Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology 2011;76(8):686-692.
20. The clinical profile of optic neuritis. Experience of the optic neuritis treatment trial. Optic Neuritis Study Group. Arch Ophthalmol 1991;109(12):1673-1678.
21. Hickman SJ, Dalton CM, Miller DH, Plant GT. Management of acute optic neuritis. Lancet 2002;360(9349):1953-1962.
22. Miller DH, Chard DT, Ciccarelli O. Clinically isolated syndromes. Lancet Neurol 2012; 11(2):157-169.
23. Pittock SJ, Debruyne J, Krecke KN, et al. Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain 2010;133(9):2626-2634.
24. Miller DH, Weinshenker BG, Filippi M, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 2008;14(9):1157-1174.
25. de Seze J, Stojkovic T, Breteau G, et al. Acute myelopathies: clinical, laboratory and outcome profiles in 79 cases. Brain 2001; 124(pt 8):1509-1521.
26. Scott TF, Frohman EM, De Seze J, et al. Evidence-based guideline: clinical evaluation and treatment of transverse myelitis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2011;77(24):2128-2134.
27. Tartaglino LM, Friedman DP, Flanders AE, et al. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology 1995;195(3): 725-732.
28. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol 2007;6(9):805-815.
29. Nishiyama Y, Yamamoto Y, Fukunaga K, et al. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis. J Nucl Med 2006;47(10): 1571-1576.
30. Lachenal F, Cotton F, Desmurs-Clavel H, et al. Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: report of 6 cases and systematic review of the literature. J Neurol 2006;253(10):1267-1277.
31. Pretorius PM, Quaghebeur G. The role of MRI in the diagnosis of MS. Clin Radiol 2003;58(6):434-448.
32. Gean-Marton AD, Vezina LG, Marton KI, et al. Abnormal corpus callosum: a sensitive and specific indicator of multiple sclerosis. Radiology 1991;180(1):215-221.
33. Fazekas F, Barkhof F, Filippi M. Unenhanced and enhanced magnetic resonance imaging in the diagnosis of multiple sclerosis. J Neurol Neurosurg Psychiatry 1998;64(suppl 1):S2-S5.
34. Charil A, Yousry TA, Rovaris M, et al. MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation". Lancet Neurol 2006;5(10):841-852.
35. Rocca MA, Anzalone N, Falini A, Filippi M. Contribution of magnetic resonance imaging to the diagnosis and monitoring of multiple sclerosis. Radiol Med 2013; 118(2):251-264.